Peter J. Leary

2.4k total citations
68 papers, 1.3k citations indexed

About

Peter J. Leary is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Peter J. Leary has authored 68 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 36 papers in Cardiology and Cardiovascular Medicine and 12 papers in Surgery. Recurrent topics in Peter J. Leary's work include Pulmonary Hypertension Research and Treatments (47 papers), Cardiovascular Function and Risk Factors (11 papers) and Vascular Anomalies and Treatments (11 papers). Peter J. Leary is often cited by papers focused on Pulmonary Hypertension Research and Treatments (47 papers), Cardiovascular Function and Risk Factors (11 papers) and Vascular Anomalies and Treatments (11 papers). Peter J. Leary collaborates with scholars based in United States, United Kingdom and Canada. Peter J. Leary's co-authors include Ryan J. Tedford, David Ralph, Catherine L. Hough, Emmanouil Tampakakis, Brian A. Houston, Edward K. Kasper, Steven M. Kawut, Stuart D. Russell, Todd M. Kolb and Samuel G. Rayner and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Peter J. Leary

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Leary United States 20 691 682 272 180 174 68 1.3k
William W. Stringer United States 23 708 1.0× 654 1.0× 199 0.7× 108 0.6× 93 0.5× 73 1.7k
Elisabeth Laßnig Austria 17 375 0.5× 1.4k 2.1× 382 1.4× 149 0.8× 149 0.9× 38 2.0k
Christoph Spes Germany 13 392 0.6× 465 0.7× 481 1.8× 132 0.7× 183 1.1× 19 1.2k
Marco Vicenzi Italy 22 849 1.2× 1.6k 2.3× 221 0.8× 98 0.5× 133 0.8× 68 2.3k
Eero Pesonen Finland 20 239 0.3× 218 0.3× 391 1.4× 101 0.6× 209 1.2× 55 1.1k
Aditya Jain United States 21 469 0.7× 1.0k 1.5× 209 0.8× 52 0.3× 187 1.1× 52 1.7k
Masanobu Ishii Japan 19 149 0.2× 687 1.0× 347 1.3× 89 0.5× 90 0.5× 113 1.1k
Alfons Gegenhuber Austria 18 281 0.4× 794 1.2× 239 0.9× 69 0.4× 198 1.1× 24 1.3k
Hagen Kälsch Germany 27 427 0.6× 1.9k 2.7× 933 3.4× 186 1.0× 317 1.8× 73 2.8k
Yoichi Inaba United States 10 387 0.6× 967 1.4× 192 0.7× 80 0.4× 96 0.6× 13 1.4k

Countries citing papers authored by Peter J. Leary

Since Specialization
Citations

This map shows the geographic impact of Peter J. Leary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Leary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Leary more than expected).

Fields of papers citing papers by Peter J. Leary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Leary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Leary. The network helps show where Peter J. Leary may publish in the future.

Co-authorship network of co-authors of Peter J. Leary

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Leary. A scholar is included among the top collaborators of Peter J. Leary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Leary. Peter J. Leary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leary, Peter J., Samuel G. Rayner, Kelley R. Branch, et al.. (2025). Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension. CHEST Journal. 168(1). 189–199.
2.
Kolaitis, Nicholas A., Jonathan Singer, Sonja Bartolome, et al.. (2025). The landscape of referrals for lung transplantation in pulmonary arterial hypertension: A report from the Pulmonary Hypertension Association Registry. The Journal of Heart and Lung Transplantation. 45(1). 125–136.
3.
Xia, Lu, Olivier Boucherat, Karthik Suresh, et al.. (2024). Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension. Circulation Heart Failure. 17(11). e012067–e012067. 2 indexed citations
4.
Rayner, Samuel G., Ryan J. Tedford, Peter J. Leary, Susanna Mak, & Brian A. Houston. (2024). “This Patient Needs a Doctor, Not a Guideline!” The Zone of Uncertainty in Pulmonary Arterial Wedge Pressure Measurement. American Journal of Respiratory and Critical Care Medicine. 210(6). 712–714. 14 indexed citations
5.
Hough, Catherine L., et al.. (2023). Premorbid weight in pulmonary arterial hypertension. Pulmonary Circulation. 13(4). e12308–e12308. 1 indexed citations
6.
Chen, Delphine L., Michael S. Mulligan, Karen Ordovás, et al.. (2023). Establishing a balloon pulmonary angioplasty program for chronic thromboembolic pulmonary hypertension: A United States single-center experience. Respiratory Medicine. 211. 107215–107215. 2 indexed citations
7.
Xia, Lu, David Ralph, Samuel G. Rayner, et al.. (2023). Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes. Circulation Research. 132(3). 254–266. 28 indexed citations
8.
Marco, Teresa De, Matthew R. Lammi, John Ryan, et al.. (2023). Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry. Annals of the American Thoracic Society. 20(12). 1718–1725. 7 indexed citations
9.
Rayner, Samuel G., et al.. (2022). Thyroid-stimulating hormone and mortality in pulmonary arterial hypertension. BMJ Open Respiratory Research. 9(1). e001348–e001348. 5 indexed citations
10.
Brown, Crystal, Jill M. Steiner, Peter J. Leary, J. Randall Curtis, & Ruth A. Engelberg. (2022). A World of Maximalist Medicine: Physician Perspectives on Palliative Care and End-of-life for Patients With Pulmonary Arterial Hypertension. Journal of Pain and Symptom Management. 65(4). e329–e335. 2 indexed citations
11.
Berardi, Cecilia, David A. Bluemke, Brian A. Houston, et al.. (2022). Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis study. The Journal of Heart and Lung Transplantation. 41(5). 619–625. 4 indexed citations
12.
Ralph, David, Ying Zheng, William A. Altemeier, et al.. (2022). Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. 42(2). 173–182. 17 indexed citations
13.
Emmons‐Bell, Sophia, Catherine O. Johnson, Paul A. Corris, et al.. (2021). Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study. Pulmonary Circulation. 12(1). e12020–e12020. 33 indexed citations
14.
Steinberg, Zachary L., William Lombardi, Joshua Lee, Michael S. Mulligan, & Peter J. Leary. (2021). Balloon Pulmonary Angioplasty in Chronic Totally Occluded Pulmonary Arteries: Applying Lessons Learned From the Treatment of Coronary Artery Chronic Total Occlusions. ˜The œJournal of invasive cardiology. 33(8). 3 indexed citations
15.
Houston, Brian A., David A. Bluemke, Steven M. Kawut, et al.. (2021). Associations of Angiopoietins With Heart Failure Incidence and Severity. Journal of Cardiac Failure. 27(7). 786–795. 19 indexed citations
16.
Burger, Charles D., Daniel Grinnan, David Ralph, et al.. (2020). A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care. Annals of the American Thoracic Society. 17(12). 1576–1582. 39 indexed citations
17.
Leary, Peter J., Nancy S. Jenny, David A. Bluemke, et al.. (2019). Endothelin-1, cardiac morphology, and heart failure: the MESA angiogenesis study. The Journal of Heart and Lung Transplantation. 39(1). 45–52. 14 indexed citations
18.
Leary, Peter J., Richard A. Kronmal, David A. Bluemke, et al.. (2017). Histamine H2 Receptor Polymorphisms, Myocardial Transcripts, and Heart Failure (from the Multi-Ethnic Study of Atherosclerosis and Beta-Blocker Effect on Remodeling and Gene Expression Trial). The American Journal of Cardiology. 121(2). 256–261. 14 indexed citations
19.
Krieger, Eric V., et al.. (2017). A Tale of Two Hearts: Patients with Decompensated Right Heart Failure in the Intensive Care Unit. Annals of the American Thoracic Society. 14(6). 1025–1030. 4 indexed citations
20.
Carlbom, David, et al.. (2015). Volume Overload: Prevalence, Risk Factors, and Functional Outcome in Survivors of Septic Shock. Annals of the American Thoracic Society. 12(12). 1837–1844. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026